SIRT3 and glioblastoma: We used genetic and chemical inhibition strategies to disrupt SIRT3 expression and activity in GBM cells and obtained evidence that targeting SIRT3 actually promoted RSL3-induced ferroptosis in vitro and inhibited GBM tumorigenesis and growth in vivo (Figs. 4 and 5).